- call +1-201-465-4211
- email sales@mrinsights.biz
Dermatology Drug is used in the management and treatment of diseases related to skin. Acne, psoriasis, and dermatitis are some common skin diseases.
Scope of the Report:
The classification of Dermatology Drug includes External Use, Oral and Injection, and the revenue proportion of External Use in 2015 is about 73.74%.
Dermatology Drug is widely used for Psoriasis, Skin Infections, Acne, Dermatitis and other skin diseases. Amongst these different types of skin diseases, Psoriasis was the largest revenue generating segment in 2015, and the revenue market share is about 48.04%.
The worldwide market for Dermatology Drug is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new study.
This report focuses on the Dermatology Drug in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
AbbVie
Johnson & Johnson
Bayer
Galderma
Bristol-Myers Squibb
Novartis
Pfizer
Merz Pharma
Valeant
LEO Pharma
GlaxoSmithKline
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
External Use
Oral
Injection
Market Segment by Applications, can be divided into
Psoriasis
Skin Infections
Acne
Dermatitis
Other
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Dermatology Drug product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Dermatology Drug, with price, sales, revenue and global market share of Dermatology Drug in 2017 and 2018.
Chapter 3, the Dermatology Drug competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Dermatology Drug breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Dermatology Drug market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Dermatology Drug sales channel, distributors, customers, research findings and conclusion, appendix and data source.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 Dermatology Drug Introduction
1.2 Market Analysis by Type
1.2.1 External Use
1.2.2 Oral
1.2.3 Injection
1.3 Market Analysis by Applications
1.3.1 Psoriasis
1.3.2 Skin Infections
1.3.3 Acne
1.3.4 Dermatitis
1.3.5 Other
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2014-2024)
1.4.1.2 Canada Market States and Outlook (2014-2024)
1.4.1.3 Mexico Market States and Outlook (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2014-2024)
1.4.2.2 France Market States and Outlook (2014-2024)
1.4.2.3 UK Market States and Outlook (2014-2024)
1.4.2.4 Russia Market States and Outlook (2014-2024)
1.4.2.5 Italy Market States and Outlook (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2014-2024)
1.4.3.2 Japan Market States and Outlook (2014-2024)
1.4.3.3 Korea Market States and Outlook (2014-2024)
1.4.3.4 India Market States and Outlook (2014-2024)
1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2014-2024)
1.4.4.2 Egypt Market States and Outlook (2014-2024)
1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
1.4.4.4 South Africa Market States and Outlook (2014-2024)
1.4.4.5 Turkey Market States and Outlook (2014-2024)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 AbbVie
2.1.1 Business Overview
2.1.2 Dermatology Drug Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 AbbVie Dermatology Drug Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.2 Johnson & Johnson
2.2.1 Business Overview
2.2.2 Dermatology Drug Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Johnson & Johnson Dermatology Drug Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.3 Bayer
2.3.1 Business Overview
2.3.2 Dermatology Drug Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Bayer Dermatology Drug Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.4 Galderma
2.4.1 Business Overview
2.4.2 Dermatology Drug Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Galderma Dermatology Drug Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.5 Bristol-Myers Squibb
2.5.1 Business Overview
2.5.2 Dermatology Drug Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Bristol-Myers Squibb Dermatology Drug Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.6 Novartis
2.6.1 Business Overview
2.6.2 Dermatology Drug Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Novartis Dermatology Drug Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.7 Pfizer
2.7.1 Business Overview
2.7.2 Dermatology Drug Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Pfizer Dermatology Drug Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.8 Merz Pharma
2.8.1 Business Overview
2.8.2 Dermatology Drug Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Merz Pharma Dermatology Drug Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.9 Valeant
2.9.1 Business Overview
2.9.2 Dermatology Drug Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Valeant Dermatology Drug Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.10 LEO Pharma
2.10.1 Business Overview
2.10.2 Dermatology Drug Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 LEO Pharma Dermatology Drug Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.11 GlaxoSmithKline
2.11.1 Business Overview
2.11.2 Dermatology Drug Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 GlaxoSmithKline Dermatology Drug Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
3 Global Dermatology Drug Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)
3.1 Global Dermatology Drug Sales and Market Share by Manufacturer (2017-2018)
3.2 Global Dermatology Drug Revenue and Market Share by Manufacturer (2017-2018)
3.3 Market Concentration Rate
3.3.1 Top 3 Dermatology Drug Manufacturer Market Share in 2018
3.3.2 Top 6 Dermatology Drug Manufacturer Market Share in 2018
3.4 Market Competition Trend
4 Global Dermatology Drug Market Analysis by Regions
4.1 Global Dermatology Drug Sales, Revenue and Market Share by Regions
4.1.1 Global Dermatology Drug Sales and Market Share by Regions (2014-2019)
4.1.2 Global Dermatology Drug Revenue and Market Share by Regions (2014-2019)
4.2 North America Dermatology Drug Sales and Growth Rate (2014-2019)
4.3 Europe Dermatology Drug Sales and Growth Rate (2014-2019)
4.4 Asia-Pacific Dermatology Drug Sales and Growth Rate (2014-2019)
4.5 South America Dermatology Drug Sales and Growth Rate (2014-2019)
4.6 Middle East and Africa Dermatology Drug Sales and Growth Rate (2014-2019)
5 North America Dermatology Drug by Country
5.1 North America Dermatology Drug Sales, Revenue and Market Share by Country
5.1.1 North America Dermatology Drug Sales and Market Share by Country (2014-2019)
5.1.2 North America Dermatology Drug Revenue and Market Share by Country (2014-2019)
5.2 United States Dermatology Drug Sales and Growth Rate (2014-2019)
5.3 Canada Dermatology Drug Sales and Growth Rate (2014-2019)
5.4 Mexico Dermatology Drug Sales and Growth Rate (2014-2019)
6 Europe Dermatology Drug by Country
6.1 Europe Dermatology Drug Sales, Revenue and Market Share by Country
6.1.1 Europe Dermatology Drug Sales and Market Share by Country (2014-2019)
6.1.2 Europe Dermatology Drug Revenue and Market Share by Country (2014-2019)
6.2 Germany Dermatology Drug Sales and Growth Rate (2014-2019)
6.3 UK Dermatology Drug Sales and Growth Rate (2014-2019)
6.4 France Dermatology Drug Sales and Growth Rate (2014-2019)
6.5 Russia Dermatology Drug Sales and Growth Rate (2014-2019)
6.6 Italy Dermatology Drug Sales and Growth Rate (2014-2019)
7 Asia-Pacific Dermatology Drug by Country
7.1 Asia-Pacific Dermatology Drug Sales, Revenue and Market Share by Country
7.1.1 Asia-Pacific Dermatology Drug Sales and Market Share by Country (2014-2019)
7.1.2 Asia-Pacific Dermatology Drug Revenue and Market Share by Country (2014-2019)
7.2 China Dermatology Drug Sales and Growth Rate (2014-2019)
7.3 Japan Dermatology Drug Sales and Growth Rate (2014-2019)
7.4 Korea Dermatology Drug Sales and Growth Rate (2014-2019)
7.5 India Dermatology Drug Sales and Growth Rate (2014-2019)
7.6 Southeast Asia Dermatology Drug Sales and Growth Rate (2014-2019)
8 South America Dermatology Drug by Country
8.1 South America Dermatology Drug Sales, Revenue and Market Share by Country
8.1.1 South America Dermatology Drug Sales and Market Share by Country (2014-2019)
8.1.2 South America Dermatology Drug Revenue and Market Share by Country (2014-2019)
8.2 Brazil Dermatology Drug Sales and Growth Rate (2014-2019)
8.3 Argentina Dermatology Drug Sales and Growth Rate (2014-2019)
8.4 Colombia Dermatology Drug Sales and Growth Rate (2014-2019)
9 Middle East and Africa Dermatology Drug by Countries
9.1 Middle East and Africa Dermatology Drug Sales, Revenue and Market Share by Country
9.1.1 Middle East and Africa Dermatology Drug Sales and Market Share by Country (2014-2019)
9.1.2 Middle East and Africa Dermatology Drug Revenue and Market Share by Country (2014-2019)
9.2 Saudi Arabia Dermatology Drug Sales and Growth Rate (2014-2019)
9.3 Turkey Dermatology Drug Sales and Growth Rate (2014-2019)
9.4 Egypt Dermatology Drug Sales and Growth Rate (2014-2019)
9.5 Nigeria Dermatology Drug Sales and Growth Rate (2014-2019)
9.6 South Africa Dermatology Drug Sales and Growth Rate (2014-2019)
10 Global Dermatology Drug Market Segment by Type
10.1 Global Dermatology Drug Sales, Revenue and Market Share by Type (2014-2019)
10.1.1 Global Dermatology Drug Sales and Market Share by Type (2014-2019)
10.1.2 Global Dermatology Drug Revenue and Market Share by Type (2014-2019)
10.2 External Use Sales Growth and Price
10.2.1 Global External Use Sales Growth (2014-2019)
10.2.2 Global External Use Price (2014-2019)
10.3 Oral Sales Growth and Price
10.3.1 Global Oral Sales Growth (2014-2019)
10.3.2 Global Oral Price (2014-2019)
10.4 Injection Sales Growth and Price
10.4.1 Global Injection Sales Growth (2014-2019)
10.4.2 Global Injection Price (2014-2019)
11 Global Dermatology Drug Market Segment by Application
11.1 Global Dermatology Drug Sales Market Share by Application (2014-2019)
11.2 Psoriasis Sales Growth (2014-2019)
11.3 Skin Infections Sales Growth (2014-2019)
11.4 Acne Sales Growth (2014-2019)
11.5 Dermatitis Sales Growth (2014-2019)
11.6 Other Sales Growth (2014-2019)
12 Dermatology Drug Market Forecast (2019-2024)
12.1 Global Dermatology Drug Sales, Revenue and Growth Rate (2019-2024)
12.2 Dermatology Drug Market Forecast by Regions (2019-2024)
12.2.1 North America Dermatology Drug Market Forecast (2019-2024)
12.2.2 Europe Dermatology Drug Market Forecast (2019-2024)
12.2.3 Asia-Pacific Dermatology Drug Market Forecast (2019-2024)
12.2.4 South America Dermatology Drug Market Forecast (2019-2024)
12.2.5 Middle East and Africa Dermatology Drug Market Forecast (2019-2024)
12.3 Dermatology Drug Market Forecast by Type (2019-2024)
12.3.1 Global Dermatology Drug Sales Forecast by Type (2019-2024)
12.3.2 Global Dermatology Drug Market Share Forecast by Type (2019-2024)
12.4 Dermatology Drug Market Forecast by Application (2019-2024)
12.4.1 Global Dermatology Drug Sales Forecast by Application (2019-2024)
12.4.2 Global Dermatology Drug Market Share Forecast by Application (2019-2024)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Dermatology Drug Picture
Table Product Specifications of Dermatology Drug
Figure Global Sales Market Share of Dermatology Drug by Types in 2018
Table De
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
